Cell factor model for prognosis evaluation of malignant pleural effusion patient and application

A malignant pleural effusion and prognosis assessment technology, applied in the field of diagnosis and treatment of malignant pleural effusion-related diseases, can solve the problem of low accuracy of prognosis detection methods

Pending Publication Date: 2022-05-24
XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In view of the above problems, the present invention provides a cytokine model and its application for the prognosis assessment of patients with malignant pleural effusion, which mainly solves the problems of low accuracy of existing prognostic detection methods

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cell factor model for prognosis evaluation of malignant pleural effusion patient and application
  • Cell factor model for prognosis evaluation of malignant pleural effusion patient and application
  • Cell factor model for prognosis evaluation of malignant pleural effusion patient and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0023] The first aspect of this part introduces the MPE patient prognosis evaluation model :

[0024] A cytokine model for prognostic assessment of patients with malignant pleural effusion,

[0025] Cytokine prognostic index CRPI=n1*x1+n2*x2...n32*x32; among them, n1~n32 are the coefficients shown in the following table respectively, and x1~x32 are respectively the relative expression levels of cytokines in the following table, and match one by one

[0026]

[0027]

[0028] The second aspect of this part describes the device for prognostic assessment of patients with MPE :

[0029] First, the device for evaluating the prognosis of MPE patients includes a detection unit and an analysis unit;

[0030] The detection unit detects the relative expression of cytokines in the sample;

[0031] The analysis unit uses the relative expression of cytokines as an input variable, and inputs a prediction model to analyze the prognosis status of patients with malignant pleural e...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of diagnosis and treatment of malignant pleural effusion related diseases, and relates to a cytokine model for prognosis evaluation of a malignant pleural effusion patient and application. According to the cell factor model, the cell factor score CRPI is equal to n1 * x1 + n2 * x2... n32 * x32; wherein n1-n32 are coefficients shown in the table 1 in sequence, and x1-x32 are relative expression quantities of the cell factors in the table 1 in sequence. The prognosis evaluation device comprises a detection unit and an analysis unit, the detection unit is used for detecting the relative expression quantity of cell factors in a sample; the analysis unit takes the relative expression quantity of cell factors as an input variable, inputs the input variable into the prediction model, and analyzes the prognosis state of the malignant pleural effusion patient; the equation of the prediction model is the above formula. The cell factor model for prognosis evaluation of the malignant pleural effusion patient or the prognosis evaluation device is applied to preparation of a malignant pleural effusion prognosis diagnosis reagent. According to the method, the prediction model is constructed by taking the relative expression quantity of the cell factors as an input variable, and the benign and malignant prognosis of the malignant pleural effusion patient can be accurately predicted.

Description

technical field [0001] The invention belongs to the field of diagnosis and treatment of malignant pleural effusion-related diseases, and particularly relates to a cytokine model and application for prognosis evaluation of patients with malignant pleural effusion. Background technique [0002] Malignant pleural effusion (MPE) refers to pleural effusion caused by malignant tumor originating in the pleura or metastasis of malignant tumor from other parts to the pleura. Lung adenocarcinoma is a common cause of MPE, and the appearance of MPE indicates that the tumor has spread to an advanced stage and lacks effective treatment. Therefore, establishing a simple method for analyzing some clinical indicators and laboratory test results of MPE patients, so as to judge their prognosis quickly and accurately, is very important for the clinical treatment of MPE patients. A large number of lymphocytes, pleural mesothelial cells, endothelial cells, fibroblasts and tumor cells were enrich...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G16B25/00G16B40/00G16H50/30G16H70/60
CPCG16B25/00G16B40/00G16H50/30G16H70/60
Inventor 周琼王子豪韦晓山叶琳琳牛怡然彭文贝张佩
Owner XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products